Improving Outcomes in Major Depression: A Focus on Cognitive Symptoms
Improving Outcomes in Major Depression: A Focus on Cognitive Symptoms
Rakesh Jain, MD, MPH
Co-Chair, 2016 U.S. Psychiatric and Mental Health Congress
Clinical Professor, Department of Psychiatry
Texas Tech Health Sciences Center School of Medicine
For full faculty bios, please call 609-371-1137.
This activity is intended for psychiatrists, primary care physicians, psychologists, physician assistants, psychiatric nurses, and other healthcare professionals who seek to improve the care of patients with MDD.
After completing this activity, participants should be able to:
- Describe the prevalence and quality of life impact of cognitive symptoms in patients with major depressive disorder (MDD)
- Routinely utilize assessment tools to identify cognitive symptoms in patients with MDD
- Outline the receptor pharmacology of available MDD agents and the evidence-based impact on therapeutic decision-making
- Optimize outcomes in patients with MDD who are experiencing cognitive symptoms
DOWNLOAD SESSION SLIDES HERE.
To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release Date: 2/28/2017
Expiration Date: 2/28/2018
Estimated time to complete: 1.0 hour
For questions regarding this educational activity, please call 609-371-1137.
There is no fee associated with this activity.
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
NACCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity awards 1.0 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour.
This continuing nursing educational activity awards up to 0.5 pharmacology hours.
North American Center for Continuing Medical Education, LLC (NACCME) is approved by the American Psychological Association to sponsor continuing education for psychologists. NACCME maintains responsibility for this program and its content.
Instructional Level: Advanced
The planning committee comprises Rakesh Jain, MD, MPH, William C. Torrey, MD, Andrew Penn, RN, MS, NP, CNS, APRN-BC; Raquel Gaerlan, Mike Kearney, Meaghan O'Brien, Randy Robbin, John Savage, and Stephanie Weiss, NACCME.
Independent Clinical Reviewer: William C. Torrey, MD, Professor of Psychiatry, Vice Chair for Clinical Services, Department of Psychiatry, Grisel School of Medicine at Dartmouth, Lebanon, New Hampshire
Nurse Planner: Andrew Penn, RN, MS, NP, CNS, APRN-BC, Psychiatric Nurse Practitioner, Kaiser Permanente, Redwood City, CA; Assistant Clinical Professor, University of California, San Francisco, CA
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Jain: Consultant—Addrenex, Allergan, Lilly, Lundbeck, Merck, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Takeda (Spouse: Lilly, Otsuka, Pamlab); Speakers Bureau—Addrenex, Allergan, Lilly, Lundbeck, Merck, Otsuka, Pamlab, Pfizer, Shionogi, Shire, Sunovion, Takeda; Research Support—AstraZeneca, Allergan, Lilly, Lundbeck, Otsuka, Pfizer, Shire, Takeda
Mr. Penn and Dr. Torrey disclosed no relevant financial relationships with any commercial interests.
Raquel Gaerlan, Mike Kearney, Meaghan O’Brien, Randy Robbin, John Savage, and Stephanie Weiss have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The off-label use of buspirone, erythropoietin, lisdexamfetamine, lithium, modafinil, tranylcypromine, and triiodothyronine for the treatment of major depressive disorder will be discussed.
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs. A PDF reader is required for print publications. Please direct technical questions email@example.com.
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2017 by North American Center for Continuing Medical Education, LLC (NACCME). All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from NACCME. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Lundbeck.